Endara Santiago A, De la Torre Juan S, Terán Fernando J, Alarcón Juan Pablo, Tovar Carla E
Cardiovascular and Thoracic surgeon, Hospital Metropolitano, Quito, Ecuador.
Spine Surgeon, Hospital Metropolitano, Quito, Ecuador.
N Am Spine Soc J. 2023 Jul 21;15:100243. doi: 10.1016/j.xnsj.2023.100243. eCollection 2023 Sep.
Synovial sarcoma (SS) is part of soft tissue sarcomas (STS). An incidence between 5% to 10% is estimated. The origin is mesenchymal mainly affecting the extremities. Being even rarer at the chest level and vertebral body, representing around 1%. Histologically, it consists of 3 variants: monophasic, biphasic, and poorly differentiated. Surgical resection is a priority when it comes to multidisciplinary management. The prognosis of patients with SS over the years has improved markedly.
Understand and evaluate the multidisciplinary management of SS considering that the SS has a lowe prevalence and highly malignancy.
We present a case of a 31-year-old male who has a history of monophasic synovial sarcoma diagnosed in 2019 and underwent surgery. Patient came back after two years without symptoms and posterior to a control MRI we observed a local recurrence of SS.
The literature was reviewed with a focus on best clinical and surgical strategy for recurrence of SS.
The patient recovered well with return to his normal daily activities. The review of the literature shows us the importance of the multidisciplinary management for the optimal clinical and surgical approach of SS recurrence.
SS represents a unique variant of STS, with malignant and metastatic potential. Being a rare pathology, an adequate multidisciplinary management is essential when providing optimal care for the patient.
滑膜肉瘤(SS)是软组织肉瘤(STS)的一部分。估计发病率在5%至10%之间。其起源于间充质,主要影响四肢。在胸部和椎体部位更为罕见,约占1%。在组织学上,它有三种变体:单相型、双相型和低分化型。在多学科管理中,手术切除是首要任务。多年来,滑膜肉瘤患者的预后有了显著改善。
鉴于滑膜肉瘤发病率低且恶性程度高,了解并评估其多学科管理。
我们报告一例31岁男性病例,该患者有单相型滑膜肉瘤病史,于2019年确诊并接受了手术。两年后患者无症状复诊,经MRI检查发现滑膜肉瘤局部复发。
回顾文献,重点关注滑膜肉瘤复发的最佳临床和手术策略。
患者恢复良好,已恢复正常日常活动。文献回顾向我们展示了多学科管理对于滑膜肉瘤复发的最佳临床和手术方法的重要性。
滑膜肉瘤是软组织肉瘤的一种独特变体,具有恶性和转移潜能。作为一种罕见的病理类型,在为患者提供最佳治疗时,充分的多学科管理至关重要。